Machine Learning–Driven Risk Prediction Model in Transthyretin Amyloid Cardiomyopathy

Study limitation reported by the research below: “The 'practice changing' flag is applied cautiously — the model outperforms established staging systems, but prospective clinical implementation has not been tested.”